Validity Reliability of The Dubousset Functional Test in Stroke Patients

Increased muscle tone, decreased normal range of motion, and functional impairments may result in decreased load on the affected limb, deviations in gait patterns, balance and coordination disorders in individuals with stroke.

In the literature, there are many scales that evaluate balance and functional performance in stroke. However there is no validity and reliability study of Dubousset Function Test developed to evaluate balance and functional performance of stroke. For this reason, the aim of study is to examine the validity and reliability of Dubousset Function Test in stroke patients.

Study Overview

• Status: Completed
• Conditions: Balance; Distorted; Walking, Difficulty; Stroke Syndrome
• Intervention / Treatment: Other: stroke patients, balance assessment

Detailed Description

While the ambulation ability is completely lost in some patients after stroke, impaired balance reactions and increased postural oscillations cause an increase in the fear of falling and the risk of falling in stroke patients. These disturbances cause stroke patients to make more effort to balance while standing. Balance assessment performed in individuals with stroke determines the risk of falling and is important in preventing complications that may develop due to loss of balance.

Dubousset Functional Test (DFT); A conceptually practical four-component assessment test has been proposed by Dr. Jean Dubousset to assess the functional capacity of adult individuals. The validity of the test was made in individuals with spinal deformity. DFT; It consists of four components: getting up from a chair without arms and walking 5 meters forward and backward, descending and climbing steps, transition from standing to sitting on the ground, and the dual task test in which the individual walks while counting down from 50 at the same time. In the literature, there are many scales that evaluate balance and functional performance in stroke. However there is no validity and reliability study of Dubousset Function Test developed to evaluate balance and functional performance of stroke. For this reason, the aim of study is to examine the validity and reliability of Dubousset Function Test in stroke patients

• Study Type: Observational
• Enrollment (Actual): 61

Contacts and Locations

Study Locations

• Turkey
  • Kırıkkale, Turkey
    • Yusuf Emre Bozkurt

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Stroke patients

Description

Inclusion Criteria:

• 18 years or older,

  • Getting a diagnosis of stroke,
  • Not having cooperation and communication problems
  • To be able to walk 10 m independently with or without device

Exclusion Criteria:

• Have a neurological or orthopedic problem other than stroke that will affect functionality and balance
• Individuals with contraindications for advanced cardiovascular disease and mobilization will not be included in the study.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
stroke patients, balance assessment; Dubousset Function Test, 3-m backwards walk test, timed up and go test,Tinnetti Balance and Gait Test, Berg BalanceTest, Functional Reach Test	Other: stroke patients, balance assessment; validity relability dubousset functional test

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Tinetti Balance and Gait Test	In the test used to evaluate balance, walking score is maximum 12 points, balance score is maximum 16 points and a total of 28 points.	first day
Berg Balance Test	The BBS consists of 14 items to directly monitor the maintenance of body balance during performance	first day
Funtional Reach Test	It is used to measure both the balance of the individual functionally and the amount of dynamic reach	first day
Dubousset Function Test	The four components of the DFT included (1) the Up Walking Test: participants rose without assistance from a and seated position in a chair that did not have arms, walked 5 meters (500 cm) forward before stopping, walked backwards 5 meters, and sat again without assistance; (2) the Steps Test: from a starting position 50 cm away, volunteers climbed three stairs, turned around on the third step (top), and walked down the three steps; (3) Down and Sitting Test: from a standing position, participants sat on the ground and stood up again, using assistance as needed; (4) Dual-Tasking Test: participants walked 5 meters forward, turned around, and walked 5 meters back to the starting position while performing a working memory test (counting down from 50 by intervals of 2).	First day
timed up and go test	A standard chair is used for testing. First, the patient is asked to sit on the chair. The patient is then asked to stand up and walk regularly at a distance of 3 meters with a predetermined length, then return to the chair after 3 meters	first day
3-m backwards walk test	A distance of 3 m is measured and marked with black tape. Individuals are asked to follow the heel and black band. With the 'start' command they are asked to walk backwards quickly. When the distance of 3 m is completed, a stop is instructed. Individuals are not allowed to run during the test. They are allowed to look back if they wish. The assessor walks behind individuals throughout the test. The test is repeated 3 times, the averages are recorded	first day

Collaborators and Investigators

• Sponsor: Kırıkkale University
• Investigators: Principal Investigator: Yusuf Emre Bozkurt, PT, Kırıkkale University

Publications and helpful links

General Publications

• Diebo BG, Challier V, Shah NV, Kim D, Murray DP, Kelly JJ, Lafage R, Paulino CB, Passias PG, Schwab FJ, Lafage V. The Dubousset Functional Test is a Novel Assessment of Physical Function and Balance. Clin Orthop Relat Res. 2019 Oct;477(10):2307-2315. doi: 10.1097/CORR.0000000000000820.

Study record dates

Study Major Dates

• Study Start (Actual): November 6, 2020
• Primary Completion (Actual): February 1, 2022
• Study Completion (Actual): February 15, 2022

Study Registration Dates

• First Submitted: November 8, 2020
• First Submitted That Met QC Criteria: November 8, 2020
• First Posted (Actual): November 13, 2020

Study Record Updates

• Last Update Posted (Actual): April 19, 2022
• Last Update Submitted That Met QC Criteria: April 15, 2022
• Last Verified: April 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Stroke; Mobility Limitation
• Other Study ID Numbers: Dubousset Functional Test

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No